EXHIBIT 99.8 AMENDMENT NO. 1 TO THE INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT This Amendment (this "Amendment") to that certain Intellectual Property Transfer and License Agreement, dated May 12, 1999, (the "Agreement") between Nortel...Intellectual Property Transfer and License Agreement • December 31st, 2001 • Elastic Networks Inc • Telephone & telegraph apparatus
EXHIBIT 10.2 INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT This Intellectual Property Transfer and License Agreement (this "Agreement") is made by and between Johnson & Johnson Consumer Companies, Inc., a New Jersey corporation having an...Intellectual Property Transfer and License Agreement • April 28th, 2004 • Barrier Therapeutics Inc • Pharmaceutical preparations • New York
INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT BETWEEN NXP B.V. AND NXP HOLDING 1 B.V. DATED AS OF FEBRUARY 7, 2010Intellectual Property Transfer and License Agreement • July 16th, 2010 • Trident Microsystems Inc • Semiconductors & related devices • New York
This Intellectual Property Transfer and License Agreement (“Agreement”) is made and entered into, as of February 7, 2010 (the “Closing Date”), by and between NXP B.V., a Dutch besloten venootshap (“NXP”), and NXP Holding 1 B.V., a Dutch besloten venootshap (“Dutch Newco”).
CONTRIBUTION AGREEMENT BETWEEN and INTELLECTUAL PROPERTY TRANSFER AND LICENCE AGREEMENTIntellectual Property Transfer and License Agreement • February 3rd, 2012 • Kraton Performance Polymers, Inc. • Plastic materials, synth resins & nonvulcan elastomers
CONFIDENTIAL TREATMENT REQUESTED - CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. *** INDICATES CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION INTELLECTUAL...Intellectual Property Transfer and License Agreement • August 4th, 2010 • NXP Semiconductors N.V. • Semiconductors & related devices
CONFIDENTIAL TREATMENT REQUESTED - CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION *** INDICATES CONFIDENTIAL MATERIAL REDACTED AND SEPARATELY FILED WITH THE COMMISSION INTELLECTUAL PROPERTY...Intellectual Property Transfer and License Agreement • June 30th, 2010 • NXP Semiconductors N.V. • Semiconductors & related devices
CONTRIBUTION AGREEMENT BETWEENIntellectual Property Transfer and License Agreement • October 28th, 2011 • Kraton Performance Polymers, Inc. • Plastic materials, synth resins & nonvulcan elastomers • Delaware
a company incorporated under the laws of the State of Delaware, United States of America, and having an office at One Shell Plaza, 910 Louisiana Street, Houston, Texas 77002 (hereinafter referred to as “SOC”)
AMENDMENT NO. 1 TO JJCC INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENTIntellectual Property Transfer and License Agreement • September 10th, 2004 • Barrier Therapeutics Inc • Pharmaceutical preparations • New York
This Amendment No. 1 (the “JJCC Amendment”) is made and entered into as of September 7, 2004 by and between Johnson & Johnson Consumer Companies, Inc., a New Jersey corporation having an address at 199 Grandview Road, Skillman, New Jersey 08558 (hereinafter referred to as “JJCC”) and Barrier Therapeutics, Inc., a Delaware corporation having an address at 600 College Road East, Suite 3200, Princeton, New Jersey 08540 (hereinafter referred to as “Barrier”).
Intellectual Property Transfer and License AgreementIntellectual Property Transfer and License Agreement • May 15th, 2008 • Kronos Advanced Technologies Inc • Industrial & commercial fans & blowers & air purifing equip • California
THIS INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT (the "Agreement") is made as of March 31, 2008 (the "Effective Date"), by and between KRONOS ADVANCED TECHNOLOGIES, INC., a Nevada corporation with a principal address at 464 Common Street, Suite 301, Belmont, MA 98052 ("Kronos") and TESSERA TECHNOLOGIES, INC., a Delaware corporation having a principal address at 3099 Orchard Drive, San Jose, CA 95134 ("Tessera").
EX-10.2 5 dex102.htm INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT DATED AS OF NOV 16, 2009 EXECUTION VERSIONIntellectual Property Transfer and License Agreement • May 5th, 2020 • New York
CONFIDENTIAL TREATMENT REQUESTED - CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.
AMENDMENT NO. 1 TO JPPLP INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENTIntellectual Property Transfer and License Agreement • September 10th, 2004 • Barrier Therapeutics Inc • Pharmaceutical preparations • New York
This Amendment No. 1 (the “JPPLP Amendment”) is made and entered into as of September 7, 2004 by and between Janssen Pharmaceutica Products, L.P., a New Jersey limited partnership having a principal place of business at 1123 Trenton-Harbourton Road, Titusville, New Jersey 08628 (hereinafter referred to as “JPPLP”) and Barrier Therapeutics, Inc., a Delaware corporation having an address at 600 College Road East, Suite 3200, Princeton, New Jersey 08540 (hereinafter referred to as “Barrier”).
EXHIBIT 10.9 INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENTIntellectual Property Transfer and License Agreement • January 20th, 1999 • Arch Chemicals Inc • Chemicals & allied products • Connecticut
Intellectual Property Transfer and License AgreementIntellectual Property Transfer and License Agreement • November 9th, 2007 • DSP Group Inc /De/ • Semiconductors & related devices
ContractIntellectual Property Transfer and License Agreement • November 9th, 2009 • Virage Logic Corp • Semiconductors & related devices • New York
CONFIDENTIAL TREATMENT REQUESTED – CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.
AMENDMENT NO. 2 TO JPPLP INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENTIntellectual Property Transfer and License Agreement • August 12th, 2005 • Barrier Therapeutics Inc • Pharmaceutical preparations • New York
This Amendment No. 2 (the “2nd JPPLP Amendment”) is made and entered into as of May 12, 2005 by and between Janssen Pharmaceutica Products, L.P., a New Jersey limited partnership having a principal place of business at 1123 Trenton-Harbourton Road, Titusville, New Jersey 08628 (hereinafter referred to as “JPPLP”) and Barrier Therapeutics, Inc., a Delaware corporation having an address at 600 College Road East, Suite 3200, Princeton, New Jersey 08540 (hereinafter referred to as “Barrier”).
INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENTIntellectual Property Transfer and License Agreement • August 6th, 2007 • Terabeam, Inc. • Radio & tv broadcasting & communications equipment • Delaware
THIS INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT (this “Agreement”) is made as of July 31, 2007 by and between Terabeam, Inc., a Delaware corporation with its principal executive offices located at 2115 O’Nel Drive, San Jose, CA 95131 (“Seller”), and Civitas Wireless Solutions, LLC, a Colorado limited liability company with its principal executive offices located at 1400 Glenarm Place, Suite 100, Denver, CO 80202 (“Buyer”).
